James S. J. Manuso

James S. J. Manuso, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Opus Genetics, Inc., Supergen Inc and RespireRx Pharmaceuticals Inc. Over a trading history stretching from 20 March 2008 to 20 April 2026, the count stands at 28 filings.

The open-market side counts 6 purchases for €19k alongside 3 sales for €438k. The totals exclude 3 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 12 share grants and 4 option exercises.

The median purchase comes to €6,183.

The newest entry dates from 22 April 2026: a share grant, in Opus Genetics, Inc. The last insider purchase was made public on 24 May 2022, 1,614 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.